Friedberg, Germany

Rita Mitnacht-Kraus

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Bad Vilbel, DE (2015)
  • Friedberg, DE (2016 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Rita Mitnacht-Kraus: Pioneering Innovator Inspiring the Future

Introduction: Rita Mitnacht-Kraus, a renowned inventor hailing from Friedberg, DE, is a trailblazer in the field of technology, continuing to ignite passion for innovation among aspiring inventors worldwide.

Latest Patents: With an impressive portfolio of 15 patents, Rita Mitnacht-Kraus's recent inventions include "Antibodies against claudin 18.2 useful in cancer diagnosis" and "Antibodies useful in cancer diagnosis," showcasing her commitment to advancing cancer diagnostics through cutting-edge antibody technology.

Career Highlights: Throughout her illustrious career, Rita Mitnacht-Kraus has made significant contributions to the industry, with notable stints at leading companies such as Astellas Pharma GmbH and Ganymed Pharmaceuticals AG. Her innovative spirit and dedication to excellence have earned her recognition as a key figure in driving technological advancements.

Collaborations: Collaborating with esteemed colleagues such as Ugur Sahin and Ozlem Tureci, Rita Mitnacht-Kraus has fostered a culture of creativity and collaboration, leading to groundbreaking inventions that have revolutionized the landscape of cancer diagnosis and treatment.

Conclusion: Rita Mitnacht-Kraus stands as a beacon of inspiration for the next generation of inventors, showcasing the transformative power of innovation in shaping the future of various industries. Her pioneering work in the field of technology continues to impact lives and drive progress, leaving a lasting legacy that will inspire generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…